Clinical Report: Routine Preoperative EGD in Bariatric Surgery – Systematic Review & Meta-analysis

Overview

This systematic review and meta-analysis of 10,685 bariatric surgery cases evaluated the necessity of routine preoperative esophagogastroduodenoscopy (p-EGD). Findings reveal that while p-EGD can detect asymptomatic lesions and occasionally alter management, the majority of findings do not impact surgical decisions, especially in asymptomatic patients.

Background

Preoperative esophagogastroduodenoscopy (p-EGD) before bariatric surgery (BS) is debated internationally, with European and Italian guidelines recommending routine use, while American guidelines suggest selective use based on symptoms. The procedure is safe and can detect lesions that might influence surgical planning or postoperative outcomes. However, concerns exist regarding its cost, invasiveness, and low yield of clinically significant findings in asymptomatic patients. This review addresses the clinical utility and justification for routine p-EGD in BS patients.

Data Highlights

Key Findings

• Routine p-EGD detects abnormalities in a small proportion (~2%) of asymptomatic bariatric surgery patients, rarely altering treatment plans.
• There is a weak correlation between upper gastrointestinal symptoms and p-EGD findings, supporting selective rather than universal screening.
• Some early malignancies have been detected preoperatively, but these are rare and not consistently found across populations.
• Routine p-EGD may be more justified in procedures where postoperative endoscopic access is limited, such as gastric bypass.
• Cost, invasiveness, and minimal risk of p-EGD argue against its routine use in all patients, especially in regions with low gastric cancer prevalence.
• Focusing p-EGD on symptomatic patients can reduce unnecessary procedures by up to 80% without compromising patient safety.

Clinical Implications

Clinicians should consider a selective approach to preoperative EGD in bariatric surgery candidates, prioritizing patients with upper gastrointestinal symptoms or risk factors. Routine p-EGD in all patients may lead to unnecessary procedures without significant benefit, especially in low-risk populations. Tailoring endoscopic evaluation can optimize resource use and patient comfort while maintaining safety.

Conclusion

Routine preoperative EGD in bariatric surgery patients has limited utility in asymptomatic individuals and should be reserved for those with symptoms or specific risk factors. This selective strategy balances clinical benefit with procedural risks and healthcare resource allocation.

References

1. European and Italian guidelines on preoperative EGD in bariatric surgery
2. American Society for Metabolic & Bariatric Surgery recommendations
3. Systematic review and meta-analysis of 10,685 bariatric surgery cases